The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...

Pharmaceuticals announced that the U.S. FDA has approved Revuforj as the first and only menin inhibitor for the treatment of ...

The Democrat faced backlash after saying he’s “excited” about Trump nominating the conspiracy theorist to lead the Department of Health and Human Services.

The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...

Colorado Gov. Jared Polis (D) is facing backlash following a comment he made about being “excited” by President-elect tapping ...

NBC News' Berkeley Lovelace Jr. reports that some officials in the Food and Drug Administration are grappling with how to ...

Should Kennedy win Senate confirmation, his critics say he is threatening the achievements of a science-based public health ...

If confirmed by the Senate, Robert F. Kennedy Jr. will oversee the $1.7 trillion agency that oversees pandemic prevention and ...

A longtime vaccine skeptic, Kennedy is an attorney who has built a loyal following over several decades of people who admire ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Aldeyra received an FDA CRL for reproxalap, necessitating an additional study for DED approval. Read why I continue to rate ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...